Location History:
- Sandwich, GB (2003)
- Groton, CT (US) (2005 - 2006)
- East Lyme, CT (US) (2004 - 2010)
Company Filing History:
Years Active: 2003-2010
Title: The Innovative Contributions of Robert John Maguire
Introduction
Robert John Maguire is a notable inventor based in East Lyme, Connecticut. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on developing compounds that address critical health issues, particularly in the treatment of diseases.
Latest Patents
Maguire's latest patents include innovative compounds such as cycloalkylamino acid derivatives. This invention relates to compounds of a specific formula and their pharmaceutically acceptable salts, prodrugs, solvates, or hydrates. These compounds are particularly useful in treating hyperproliferative diseases and autoimmune diseases in mammals, especially humans. Another significant patent involves NEP inhibitors for treating cardiovascular disorders. This invention outlines preferred NEP inhibitors that can be utilized in various pharmaceutical compositions.
Career Highlights
Robert John Maguire has built a successful career at Pfizer Corporation, where he continues to contribute to groundbreaking research and development in pharmaceuticals. His expertise in creating innovative compounds has positioned him as a valuable asset in the industry.
Collaborations
Maguire has collaborated with esteemed colleagues, including David John Bull and Charlotte Moira Norfor Allerton. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Robert John Maguire's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.